XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 27,893 $ 27,862 $ 90,489 $ 83,966
General and administrative 6,888 8,207 23,225 24,938
Total operating expenses 34,781 36,069 113,714 108,904
Loss from operations (34,781) (36,069) (113,714) (108,904)
Interest and other income, net 2,299 1,015 7,368 1,340
Net loss $ (32,482) $ (35,054) $ (106,346) $ (107,564)
Net loss per share, basic $ (0.43) $ (0.51) $ (1.42) $ (2.21)
Net loss per share, diluted $ (0.43) $ (0.51) $ (1.42) $ (2.21)
Weighted-average shares used in computing net loss per share, basic 75,342,495 68,652,859 74,815,274 48,710,433
Weighted-average shares used in computing net loss per share, diluted 75,342,495 68,652,859 74,815,274 48,710,433